SLC7A4 |
O43246
|
solute carrier family 7 member 4
|
Transporter
|
2.8E-07 |
0.666 |
0.423 |
KIR2DL5B |
Q8NHK3
|
killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 5B
|
|
|
0.682 |
0.423 |
SETDB2 |
Q96T68
|
SET domain bifurcated histone lysine methyltransferase 2
|
|
2.3E-05 |
0.716 |
0.423 |
KIR2DL5A |
Q8N109
|
killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 5A
|
Receptor
|
|
0.711 |
0.423 |
KIR2DS3 |
Q14952
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 3
|
Receptor
|
|
0.716 |
0.423 |
CD53 |
P19397
|
CD53 molecule
|
|
2.3E-03 |
0.736 |
0.423 |
IGK |
|
immunoglobulin kappa locus
|
|
|
0.647 |
0.462 |
CD8B |
P10966
|
CD8b molecule
|
|
4.0E-04 |
0.674 |
0.462 |
AK3 |
Q9UIJ7
|
adenylate kinase 3
|
Kinase
|
1.1E-04 |
0.691 |
0.462 |
DERL3 |
Q96Q80
|
derlin 3
|
Receptor
|
2.2E-04 |
0.691 |
0.462 |
FCRL5 |
Q96RD9
|
Fc receptor like 5
|
Cell adhesion
|
4.6E-17 |
0.722 |
0.462 |
TCL1A |
P56279
|
T cell leukemia/lymphoma 1A
|
|
5.7E-10 |
0.558 |
0.500 |
TCL1B |
O95988
|
T cell leukemia/lymphoma 1B
|
|
1.0E-02 |
0.561 |
0.500 |
CD52 |
P31358
|
CD52 molecule
|
|
0.40 |
0.615 |
0.500 |
MIR16-1 |
|
microRNA 16-1
|
|
|
0.623 |
0.500 |
DLEU2 |
|
deleted in lymphocytic leukemia 2
|
|
|
0.650 |
0.500 |
CHST11 |
Q9NPF2
|
carbohydrate sulfotransferase 11
|
Enzyme
|
0.41 |
0.682 |
0.500 |
FCRL4 |
Q96PJ5
|
Fc receptor like 4
|
Cell adhesion
|
7.9E-10 |
0.670 |
0.500 |
IGHG1 |
P01857
|
immunoglobulin heavy constant gamma 1 (G1m marker)
|
|
|
0.700 |
0.500 |
RARS1 |
P54136
|
arginyl-tRNA synthetase 1
|
|
3.3E-08 |
0.604 |
0.538 |
CLEC4D |
Q8WXI8
|
C-type lectin domain family 4 member D
|
|
2.5E-06 |
0.587 |
0.538 |
PIM2 |
Q9P1W9
|
Pim-2 proto-oncogene, serine/threonine kinase
|
Kinase
|
0.95 |
0.606 |
0.538 |
DOK1 |
Q99704
|
docking protein 1
|
|
2.9E-02 |
0.650 |
0.538 |
CRYGEP |
|
crystallin gamma E, pseudogene
|
|
|
0.666 |
0.538 |
CD180 |
Q99467
|
CD180 molecule
|
Receptor
|
6.8E-05 |
0.682 |
0.538 |